The Andrew Weil Center for Integrative Medicine at the University of Arizona College of Medicine – Tucson presents a FREE sponsored webinar from San Francisco’s Pendulum Therapeutics Inc.:
![[Graphical design next to circular image of a woman's exposed midriff with her hands above and below her belly]](/sites/default/files/pendulum_gut_microbiome_webinar_awcim-2.png "Graphical design next to circular image of a woman's exposed midriff with her hands above and below her belly")
Topic: “Impacting Metabolic Health Through the Gut Microbiome”
Explore the latest research on Akkermansia muciniphila, a pivotal gut microbiome player known for its role in supporting gut barrier integrity and metabolic health. Discover how A. muciniphila, along with novel strains like C. butyricum, can enhance microbiome resilience and optimize metabolic function.
Thursday, Jan. 9, 2025, at 2:00 p.m. Arizona Time (4 p.m., EST)
Presenter: Adam Perlman, MD, MPH, FACP ![[Adam Perlman, MD, MPH, FACP]](/sites/default/files/styles/very_small_image/public/120930_adam_perlman_md_mph_600x900px.jpg?itok=8qTK_g6D "Adam Perlman, MD, MPH, FACP")
Dr. Perlman, chief medical officer at Pendulum Therapeutics, is board-certified in Internal Medicine and specializes in Integrative and Functional Medicine. He leads the medical team at Pendulum Therapeutics, a probiotics company at the forefront of microbiome science with significant backing from Sequoia Capital and the Mayo Clinic. Dr. Perlman previously served as the Director of Integrative Health and Wellbeing for Mayo Clinic. Prior to that, he served as the Associate Vice President for Health and Wellness for the Duke University Health System. Dr. Perlman received his BA from Tufts University, his MD from the Boston University School of Medicine, and his MPH from the Boston University School of Public Health.
For additional events from the Andrew Weil Center for Integrative Medicine, click here.
VIRTUAL